Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens.
about
Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell linesBiological response modifiers in cancerHuman IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsAdecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside.Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies.
P2860
Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Anti-self antibodies selected ...... ated differentiation antigens.
@ast
Anti-self antibodies selected ...... ated differentiation antigens.
@en
type
label
Anti-self antibodies selected ...... ated differentiation antigens.
@ast
Anti-self antibodies selected ...... ated differentiation antigens.
@en
prefLabel
Anti-self antibodies selected ...... ated differentiation antigens.
@ast
Anti-self antibodies selected ...... ated differentiation antigens.
@en
P2093
P356
P1476
Anti-self antibodies selected ...... ated differentiation antigens.
@en
P2093
P2888
P304
P356
10.1007/PL00006684
P577
2001-05-01T00:00:00Z
P6179
1004187732